Next Article in Journal
Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer
Previous Article in Journal
The Prospect and Challenges to the Flow of Liquid Biopsy in Africa
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview

Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics

1
N. I. Pirogov Russian National Medical University, Russian Federal Ministry of Health, 117997 Moscow, Russia
2
Federal State Institution V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology National Scientific Research Center on Addictions of the Ministry of Healthcare of the Russian Federation, 119002 Moscow, Russia
3
Department of Biomedical and Biotechnlogical Sciences, University of Catania, 95123 Catania, Italy
4
Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123 Catania, Italy
5
Department of Fundamental and Applied Neurobiology, Serbsky National Research Center for Social and Forensic Psychiatry, Ministry of Health and Social Development of the Russian Federation, 119034 Moscow, Russia
6
Laboratory of Anatomy-Histology-Embryology, Medical School of Heraklion, University of Crete, Voutes, 71110 Heraklion, Crete, Greece
7
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov, First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenov University), 119048 Moscow, Russia
8
Institute of Cancer Therapeutics, University of Bradford, West Yorkshire BD7 1DP, UK
9
Department of Neurology, School of Medicine, University of Crete, 71110 Heraklion, Crete, Greece
10
Department of Neurology, Henry Ford Hospital, Detroit, MI 48202, USA
11
Centre of Toxicology Science and Research, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece
12
Department of Analytical Toxicology, Sechenov University, 119048 Moscow, Russia
*
Authors to whom correspondence should be addressed.
These authors contribute equally to this work.
Cells 2019, 8(8), 863; https://doi.org/10.3390/cells8080863
Received: 5 July 2019 / Revised: 2 August 2019 / Accepted: 6 August 2019 / Published: 9 August 2019
  |  
PDF [1443 KB, uploaded 16 August 2019]
  |  

Abstract

Glioblastoma multiforme is the most aggressive malignant tumor of the central nervous system. Due to the absence of effective pharmacological and surgical treatments, the identification of early diagnostic and prognostic biomarkers is of key importance to improve the survival rate of patients and to develop new personalized treatments. On these bases, the aim of this review article is to summarize the current knowledge regarding the application of molecular biology and proteomics techniques for the identification of novel biomarkers through the analysis of different biological samples obtained from glioblastoma patients, including DNA, microRNAs, proteins, small molecules, circulating tumor cells, extracellular vesicles, etc. Both benefits and pitfalls of molecular biology and proteomics analyses are discussed, including the different mass spectrometry-based analytical techniques, highlighting how these investigation strategies are powerful tools to study the biology of glioblastoma, as well as to develop advanced methods for the management of this pathology. View Full-Text
Keywords: molecular biology; proteomics; metabolomics; glioblastoma; mass spectrometry; biomarkers; miRNAs; DNA; proteins molecular biology; proteomics; metabolomics; glioblastoma; mass spectrometry; biomarkers; miRNAs; DNA; proteins
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Silantyev, A.S.; Falzone, L.; Libra, M.; Gurina, O.I.; Kardashova, K.S.; Nikolouzakis, T.K.; Nosyrev, A.E.; Sutton, C.W.; Mitsias, P.D.; Tsatsakis, A. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 2019, 8, 863.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top